Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Gross Margin (2018 - 2025)

TELA Bio has reported Gross Margin over the past 8 years, most recently at 65.91% for Q4 2025.

  • Quarterly results put Gross Margin at 65.91% for Q4 2025, up 233.0% from a year ago — trailing twelve months through Dec 2025 was 67.69% (up 61.0% YoY), and the annual figure for FY2025 was 67.69%, up 61.0%.
  • Gross Margin for Q4 2025 was 65.91% at TELA Bio, down from 67.52% in the prior quarter.
  • Over the last five years, Gross Margin for TELA hit a ceiling of 70.38% in Q2 2023 and a floor of 58.96% in Q1 2021.
  • Median Gross Margin over the past 5 years was 67.54% (2025), compared with a mean of 66.35%.
  • Biggest five-year swings in Gross Margin: skyrocketed 785bps in 2021 and later plummeted -481bps in 2024.
  • TELA Bio's Gross Margin stood at 67.58% in 2021, then grew by 4bps to 70.35% in 2022, then fell by -3bps to 68.38% in 2023, then decreased by -7bps to 63.58% in 2024, then increased by 4bps to 65.91% in 2025.
  • The last three reported values for Gross Margin were 65.91% (Q4 2025), 67.52% (Q3 2025), and 69.84% (Q2 2025) per Business Quant data.